Healthcare provider profile · identity verified

Eileen B Reilly, MD

Family Practice · ORCHARD PARK, NY · NPI 1871586420

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	497	55
Levothyroxine Sodium	Levothyroxine Sodium	490	86
Furosemide	Furosemide	403	70
Atorvastatin Calcium	Atorvastatin Calcium	399	67
Metoprolol Succinate	Metoprolol Succinate	327	58
Pantoprazole Sodium	Pantoprazole Sodium	287	58
Memantine Hcl	Memantine Hcl	284	46
Amlodipine Besylate	Amlodipine Besylate	263	51
Omeprazole	Omeprazole	234	47
Gabapentin	Gabapentin	223	38
Lisinopril	Lisinopril	216	39
Donepezil Hcl	Donepezil Hcl	214	37
Sertraline Hcl	Sertraline Hcl	193	31
Tamsulosin Hcl	Tamsulosin Hcl	175	27
Escitalopram Oxalate	Escitalopram Oxalate	169	29
Carbidopa-Levodopa	Carbidopa/Levodopa	157	25
Rosuvastatin Calcium	Rosuvastatin Calcium	144	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	140	24
Mirtazapine	Mirtazapine	136	26
Metoprolol Tartrate	Metoprolol Tartrate	129	37
Trazodone Hcl	Trazodone Hcl	129	29
Fluticasone Propionate	Fluticasone Propionate	123	32
Potassium Chloride	Potassium Chloride	117	27
Quetiapine Fumarate	Quetiapine Fumarate	117	25
Tramadol Hcl	Tramadol Hcl	116	31
Latanoprost	Latanoprost	110	18
Xarelto	Rivaroxaban	108	16
Lantus	Insulin Glargine,hum.Rec.Anlog	107	13
Allopurinol	Allopurinol	104	17
Buspirone Hcl	Buspirone Hcl	103	14
Carvedilol	Carvedilol	103	17
Chlorhexidine Gluconate	Chlorhexidine Gluconate	99	18
Oseltamivir Phosphate	Oseltamivir Phosphate	94	94
Trulicity	Dulaglutide	93	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	88	34
Divalproex Sodium	Divalproex Sodium	87	16
Metformin Hcl	Metformin Hcl	87	17
Duloxetine Hcl	Duloxetine Hcl	85	16
Losartan Potassium	Losartan Potassium	85	16
Famotidine	Famotidine	83	23
Clopidogrel	Clopidogrel Bisulfate	79	14
Hydralazine Hcl	Hydralazine Hcl	76	suppressed
Lorazepam	Lorazepam	72	16
Olanzapine	Olanzapine	72	suppressed
Bumetanide	Bumetanide	71	13
Baclofen	Baclofen	70	13
Fluoxetine Hcl	Fluoxetine Hcl	69	suppressed
Spironolactone	Spironolactone	69	14
Arexvy	Rsvpref3 Antigen/As01e/Pf	68	67
Warfarin Sodium	Warfarin Sodium	65	suppressed
Ondansetron Hcl	Ondansetron Hcl	64	30
Simvastatin	Simvastatin	58	12
Levetiracetam	Levetiracetam	57	suppressed
Midodrine Hcl	Midodrine Hcl	57	14
Myrbetriq	Mirabegron	57	suppressed
Irbesartan	Irbesartan	50	suppressed
Folic Acid	Folic Acid	49	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	48	12
Triamcinolone Acetonide	Triamcinolone Acetonide	48	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	suppressed
Humalog	Insulin Lispro	46	suppressed
Methadone Hcl	Methadone Hcl	46	suppressed
Digoxin	Digoxin	41	suppressed
Lactulose	Lactulose	40	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Prednisone	Prednisone	39	22
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Finasteride	Finasteride	38	suppressed
Lansoprazole	Lansoprazole	38	suppressed
Rivastigmine	Rivastigmine	38	suppressed
Aripiprazole	Aripiprazole	36	suppressed
Lamotrigine	Lamotrigine	36	suppressed
Valsartan	Valsartan	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Santyl	Collagenase Clostridium Hist.	32	suppressed
Sucralfate	Sucralfate	32	suppressed
Calcitriol	Calcitriol	31	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Nuplazid	Pimavanserin Tartrate	30	suppressed
Diltiazem Hcl	Diltiazem Hcl	29	suppressed
Jardiance	Empagliflozin	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	13
Clonazepam	Clonazepam	28	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Risperidone	Risperidone	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	18
Montelukast Sodium	Montelukast Sodium	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	11
Morphine Sulfate	Morphine Sulfate	26	21
Movantik	Naloxegol Oxalate	26	suppressed
Brilinta	Ticagrelor	25	suppressed
Dutasteride	Dutasteride	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Lurasidone Hcl	Lurasidone Hcl	25	suppressed
Tiotropium Bromide	Tiotropium Bromide	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Atenolol	Atenolol	24	suppressed
Nystatin	Nystatin	23	11
Torsemide	Torsemide	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Amoxicillin	Amoxicillin	22	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Timolol Maleate	Timolol Maleate	22	suppressed
Amantadine	Amantadine Hcl	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Cephalexin	Cephalexin	20	15
Hydrocortisone	Hydrocortisone	20	suppressed
Primidone	Primidone	20	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	suppressed
Oxcarbazepine	Oxcarbazepine	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Celecoxib	Celecoxib	16	suppressed
Clonidine	Clonidine	16	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Metolazone	Metolazone	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Donepezil Hcl Odt	Donepezil Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Entacapone	Entacapone	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Topiramate	Topiramate	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	12	11
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	12	suppressed
Glipizide	Glipizide	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error